Evidence map›Paper›PMID 36889346›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2022

Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals.

J Scott Weese, Guilherme Antonio Da Costa Junior, Bruno Gonzalez-Zorn, Laura Y Hardefeldt, Jorge Matheu, Gerard Moulin, Stephen W Page, Ruby Singh, Junxia Song, Olafur Valsson

Open access · hybridFull text read
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 8 countries.

J Scott WeeseUNIVERSITY OF GUELPH, ONTARIO, CANADA.
Guilherme Antonio Da Costa JuniorMISSION OF BRAZIL TO THE EUROPEAN UNION, BRUSSELS, BELGIUM.
Bruno Gonzalez-ZornCOMPLUTENSE UNIVERSITY, MADRID, SPAIN.
Laura Y HardefeldtUNIVERSITY OF MELBOURNE, MELBOURNE, AUSTRALIA.
Jorge MatheuWORLD HEALTH ORGANIZATION, GENEVA, SWITZERLAND.
Gerard MoulinFRENCH AGENCY FOR FOOD, ENVIRONMENTAL AND OCCUPATIONAL HEALTH & SAFETY (ANSES).
Stephen W PageVETERINARY CLINICAL PHARMACOLOGY AND TOXICOLOGY, ADVANCED VETERINARY THERAPEUTICS IN NEWTOWN, AUSTRALIA.
Ruby SinghFDA, ROCKVILLE, MARYLAND, USA.
Junxia SongFOOD AND AGRICULTURE ORGANIZATION OF UNITED NATIONS, ROME, ITALY.
Olafur ValssonWORLD ORGANISATION FOR ANIMAL HEALTH, PARIS, FRANCE.
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FREuropean Union · BEFood and Agriculture Organization of the United Nations · ITOrganisation Mondiale de la Santé Animale · FRThe University of Sydney · AUUnited States Food and Drug Administration · USUniversidad Complutense de Madrid · ESUniversity of Guelph · CAWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

The majority of antimicrobials that are produced are administered to animals, particularly food animals. While the overall impact of antimicrobial use in animals on antimicrobial resistance in humans and the environment is unclear, it undeniably has a role. Yet, some degree of antimicrobial use in animals is necessary for animal health and welfare purposes. Balancing the benefits and risks of antimicrobial use in animals is challenging because of the complexity of the problem and limitations in available data. However, a range of measures can be implemented to reduce, refine and optimize antimicrobial use in animals, with a goal of minimizing the impact on human and environmental health while maintaining necessary therapeutic use in animals. A pandemic instrument can provide the necessary foundation for the whole-of-society and whole-of government One Health approach that is required to strengthen surveillance, communication, collaboration, and action.

Indexed as

Anti-Infective AgentsAnimalsEnvironmental HealthHumansAnti-Infective AgentsAgricultureAntimicrobial ResistanceAntimicrobial StewardshipOne Health

Identifiers

PMID36889346
PMCPMC10009376
OpenAlexW4323642620

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.